Getting value from the waste: recombinant production of a sweet protein by Lactococcus lactis grown on cheese whey by Boumaiza, Mohamed et al.
Boumaiza et al. Microb Cell Fact  (2018) 17:126  
https://doi.org/10.1186/s12934-018-0974-z
RESEARCH
Getting value from the waste: 
recombinant production of a sweet protein 
by Lactococcus lactis grown on cheese whey
Mohamed Boumaiza1, Andrea Colarusso1, Ermenegilda Parrilli1, Elena Garcia‑Fruitós2, Angela Casillo1, 
Anna Arís2, Maria Michela Corsaro1, Delia Picone1, Serena Leone1*  and Maria Luisa Tutino1*
Abstract 
Background: Recent biotechnological advancements have allowed for the adoption of Lactococcus lactis, a typi‑
cal component of starter cultures used in food industry, as the host for the production of food‑grade recombinant 
targets. Among several advantages, L. lactis has the important feature of growing on lactose, the main carbohydrate in 
milk and a majoritarian component of dairy wastes, such as cheese whey.
Results: We have used recombinant L. lactis NZ9000 carrying the nisin inducible pNZ8148 vector to produce MNEI, a 
small sweet protein derived from monellin, with potential for food industry applications as a high intensity sweetener. 
We have been able to sustain this production using a medium based on the cheese whey from the production of 
ricotta cheese, with minimal pre‑treatment of the waste. As a proof of concept, we have also tested these conditions 
for the production of MMP‑9, a protein that had been previously successfully obtained from L. lactis cultures in stand‑
ard growth conditions.
Conclusions: Other than presenting a new system for the recombinant production of MNEI, more compliant with its 
potential applications in food industry, our results introduce a strategy to valorize dairy effluents through the synthe‑
sis of high added value recombinant proteins. Interestingly, the possibility of using this whey‑derived medium relied 
greatly on the choice of the appropriate codon usage for the target gene. In fact, when a gene optimized for L. lactis 
was used, the production of MNEI proceeded with good yields. On the other hand, when an E. coli optimized gene 
was employed, protein synthesis was greatly reduced, to the point of being completely abated in the cheese whey‑
based medium. The production of MMP‑9 was comparable to what observed in the reference conditions.
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Background
Lactic acid bacteria (LAB) are traditional components 
of starter preparations and have been used for cen-
turies in the manufacturing of fermented food [1]. 
More recently, they have attracted much attention for 
their biotechnological potential, finding use in a vari-
ety of applications. Lactococcus lactis (L. lactis), a pro-
totypical member of this family, is a gram-positive, 
non-sporulating, facultative anaerobic bacterium and a 
common gut colonizer, which has been used for centuries 
by the cheese-making industry, thus receiving the Gen-
erally Recognized As Safe (GRAS) status [2, 3]. Outside 
food industry, L. lactis has been successfully exploited 
for its metabolic machinery, to produce and accumulate 
high value chemicals, such as ethanol, l-lactate, diacetyl, 
acetaldehyde, but also l-alanine, mannitol and other 
sweeteners and group B vitamins [3, 4]. Much of the bio-
technological advances that have taken place for L. lactis 
own to the achievement of complete genome sequencing 
of a few strains [5, 6], which has allowed for metabolic 
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engineering manipulations, aimed at favoring the pro-
duction of specific metabolites of industrial interest [4, 
7–10]. In this respect, it is noteworthy the production 
of bacteriocins, antimicrobial peptides with a number of 
applications, ranging from food-preservation to anti-bio-
film activity in clinical set-ups [11–13].
Together with genome sequencing, the discovery and 
development of both constitutive and inducible expres-
sion systems for L. lactis has favored its development as 
a cell factory for the production of recombinant proteins 
[2, 14, 15]. Being a food-grade microorganism, devoid 
of endotoxins, L. lactis is very convenient for the heter-
ologous production, both intracellular and secreted, of a 
number of therapeutics and vaccines, recently reviewed 
by Song et al. in [3].
The greatest boost in the use of L. lactis for the produc-
tion of heterologous protein has been the development of 
the nisin controlled gene expression (NICE) system [16], 
which has been used in combination with the nisin-nega-
tive NZ9000 strain and its derivatives for the production 
of numerous recombinant protein targets [17].
In parallel with their use as molecular biology tools, 
L. lactis and other LAB have found space in the field of 
bioconversions, where their ability to digest the compo-
nents of industrial effluents has been coupled to the pro-
duction of added value chemicals [18–25]. In the case of 
LAB, their ability to digest lactose has been functional 
to the possibility of using them for the valorization of 
dairy wastes. Cheese whey (CW), the serum portion of 
milk that survives the process of cheese making, is in fact 
one of the most polluting by-products of dairy industry 
and its disposal imposes a considerable economic bur-
den on cheese producers, due to its high biological and 
chemical oxygen demand [26]. The composition of CW 
varies according to its origin, but, in general, it is a nutri-
tious mixture, containing roughly half the solids of raw 
milk. In particular, most of the lactose (that survives 
protein agglutination), roughly 20% of the original milk 
proteins, some vitamins and minerals are still present in 
CW, which is in fact often used as feeding for livestock 
[27–29]. In addition to its use “as is”, strategies for the 
valorization of CW have been proposed, often employing 
microbes to convert it in biomass or added value com-
pounds, like ethanol, organic acids or bacteriocins [18, 
20, 28, 30–32]. Nonetheless, to our knowledge, this mate-
rial has never been used to sustain the production of high 
value recombinant proteins.
We here describe the use of the CW resulting from the 
making of mozzarella and ricotta cheese, to sustain the 
growth of L. lactis NZ9000 and the heterologous pro-
duction of the small (~ 12 kDa), globular protein MNEI. 
MNEI is a single chain derivative of the plant (Diosco-
reophyllum cumminsii) protein monellin [33, 34] and 
has received much attention for its high intensity sweet-
ness. Due to this potential industrial interest, several bio-
technological strategies have been devised to produce 
it, exploiting a variety of host systems [35, 36]. MNEI is 
one of the best characterized members of the sweet pro-
teins family and it has been object of protein engineering 
to improve its taste profile and physicochemical charac-
teristics, trying to meet the needs of the food and bever-
age industry [37–43]. In light of its potential applications 
in food preparations, the optimization of a food-grade 
production system becomes particularly important. The 
possibility of coupling such system to the valorization of 
a largely available industrial by-product makes our strat-
egy particularly appealing. Moreover, we demonstrate 
that these growth conditions can be successfully used to 
produce other recombinant proteins in L. lactis strains. 
In particular, we show that the expression levels of the 
previously characterized protein MMP-9 in L. lactis [44, 
45] are comparable in the CW-based medium and in the 
reference conditions in rich medium.
Results
Expression of MNEI in L. lactis NZ9000
The synthetic genes coding for MNEI with optimized 
codon usage for E. coli (MNEI-ec) and L. lactis (MNEI-
ll) were cloned into the pNZ8148 vector. This was moti-
vated by the fact that previous studies aimed at the 
production of brazzein, another sweet protein, in L. lactis 
had shown the counterintuitive result of greater produc-
tion yields when employing an E. coli optimized gene 
[46–48]. In our case, the two synthetic genes differed for 
their GC content (49% and 37% for MNEI-ec and MNEI-
ll, respectively) and their sequence alignment is reported 
in Additional file 1: Figure S1. Unlike the previous results 
for brazzein, when L. lactis NZ9000 was transformed 
with the vector containing the MNEI-ec gene, negligible 
protein production was observed (Additional file 2: Fig-
ure S2). Conversely, the system carrying the pNZ8148-
MNEI-ll vector proved to be quite efficient: Fig. 1 shows 
the Coomassie stained SDS-PAGE and the western blot 
of 10  μg of total protein extracts from recombinant L. 
lactis producing MNEI. Densitometric quantification 
of the blot provided an estimate of the yield ~ 140  ng 
MNEI in 10 μg of total protein extract, corresponding to 
~ 0.40 mg of protein per liter of culture medium, which 
remains quite stable throughout the fermentation, based 
on the intensity of the bands corresponding to 2, 4 and 
16  h post-induction in comparison to purified protein 
samples.
Growth of L. lactis NZ9000 on cheese whey based media
The above experiments were all carried out in the con-
ventional growth conditions for L. lactis, namely static 
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cultures in M17 rich medium supplemented with 0.5% 
glucose (G-M17) at 30  °C. We then moved to compar-
ing the microbial growth on CW. We used the CW 
obtained as by-product of the manufacturing of ricotta, 
a typical fresh cheese from Campania, Italy. Ricotta is 
produced by heating at 90  °C the whey resulting from 
the production of “Mozzarella di Bufala Campana” and 
collecting the flocculating suspension. The residual 
watery portion constitutes the CW employed in this 
study. Upon delivery to our lab, all CW samples con-
tained variable amounts of particulate in suspension, 
formed during the cooling down of the exhausted whey. 
Several treatments have been proposed as preliminary 
workups when CW is used as a raw material for bio-
technological applications, and these range from total 
deproteinization of CW, to treatment with proteolytic 
enzymes, to supplementation with other nutrients such 
as peptone and yeast extract [20, 21]. Since we were try-
ing to set up a scalable protocol, ideally suitable to work 
on the large amounts of CW produced by a dairy indus-
try, we decided to limit the steps prior to inoculation 
of L. lactis to pH adjustment to 6.8, sterilization by 
autoclave and clarification by centrifugation of CW (ac-
CW). The average nutrients content of CW and ac-CW 
before bacterial culture is provided in Table  1. The 
counterintuitive increase in carbohydrate content upon 
sterilization might result from partial hydrolysis of lac-
tose, the main sugar of milk, to glucose and galactose. 
This would provide a higher response to the phenol 
assay used to quantify reducing carbohydrates. Despite 
pH adjustment had been performed, the lack of buffer-
ing capacity of untreated CW resulted in a drop in pH 
after sterilization, to ~ 6.2. Nonetheless, given the toler-
ance of LAB for acidic pHs, no further adjustment was 
performed. The medium was also supplemented with a 
catalytic amount (0.05%) of yeast extract as a source of 
vitamins and cofactors, to improve the utilization of the 
nutrients, still abundant in ac-CW.
Explorative experiments showed that the growth on 
the CW-based medium was accompanied by a marked 
decrease in pH, due to the production of organic acids, 
paralleling what observed during the growth in G-M17 
medium (Additional file 3: Figure S3). Therefore, since 
the proteins in CW had not been hydrolyzed, the 
growth in this medium was accompanied by additional 
protein precipitation, making it impossible to monitor 
biomass accumulation with turbidimetric methods (i.e. 
by measuring the OD600). Thus, all the growth curves 
were constructed measuring the CFUs/mL at differ-
ent time points. Figure 2 shows the comparison of the 
growth curves, while Table  2 summarizes the growth 
parameters, for L. lactis NZ9000 in the standardized 
G-M17 medium and in the ac-CW-based medium. The 
marked difference in biomass at the end of the growth 
(2.14 × 108 vs 1.04 × 109 CFU/mL in ac-CW medium 
and G-M17, respectively) is likely the result of the sig-
nificant protein deficiency of the ac-CW-based medium 
compared to G-M17 (2.3 vs 15.0 g/L, Additional file 4: 
Table S1) and of an unbalanced carbohydrates:proteins 
ratio (40:2.3 vs 10:15). Nonetheless, despite these sub-
optimal conditions, L. lactis NZ9000 could thrive in the 
CW-derived medium.
Fig. 1 Production of recombinant MNEI in G‑M17 medium. 
Coomassie‑stained SDS‑PAGE (a) and western blot (b) of the 
total protein extract (10 μg) from L. lactis NZ9000 carrying the 
pNZ8148‑MNEI‑ll vector (A–D) or the empty pNZ8148 vector (E–F). A: 
no induction; B: 2 h post‑induction; C: 4 h post induction; D: 16 h post 
induction; E: no induction; F: 4 h post induction; G: MNEI standard, 
200 ng; H: MNEI standard, 500 ng
Table 1 Mean composition and standard deviation 
of the cheese whey (CW) at reception and after sterilization/
clarification (ac-CW)
CW ac-CW
Carbohydrates (mg/mL) 27 ± 2 40 ± 5
Proteins (mg/mL) 2.4 ± 0.3 2.3 ± 0.2
Lipids (mg/mL) 12 ± 5 7 ± 3
pH 6.1 ± 0.1 6.17 ± 0.04
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Expression of recombinant MNEI on CW-based medium
Once we had ascertained the capacity of L. lactis to grow 
on the ac-CW-based medium, we checked if these con-
ditions could also sustain the expression of MNEI in the 
recombinant strain carrying the pNZ8148-MNEI-ll or 
pNZ8148-MNEI-ec vector. Both strains showed compa-
rable growth profiles to the wild type strain (not shown); 
therefore, in all subsequent experiments, protein syn-
thesis was induced after 2 h, corresponding to the mid-
exponential phase, with 10  ng/mL nisin and checked at 
different time points post-induction by Western Blot. 
Figure  3 shows the Coomassie-stained SDS-PAGE (A) 
and Western blot (B) of the total protein extracts at dif-
ferent times post induction. Despite the discussed reduc-
tion in biomass accumulation compared to the standard 
G-M17 rich medium, the yield of recombinant MNEI on 
the ac-CW-based medium seems higher than in the ref-
erence condition. Densitometric quantification of MNEI 
by western blot, in comparison with pure protein sam-
ples, allowed us to estimate a yield of 270 ng MNEI/10 μg 
total proteins 2  h after induction, i.e. almost twice the 
observed yield in G-M17 medium. The yield of protein 
per liter of culture medium was nonetheless compara-
ble to that in G-M17, i.e. ~ 0.49 mg, because of the lower 
biomass reached in ac-CW-based growth conditions. 
Interestingly, when the recombinant strain carrying the 
pNZ8148-MNEI-ec vector was grown on the ac-CW-
based medium, no protein production could be detected 
(Additional file 5: Figure S4).
Expression of MMP-9 on CW-based medium
As a proof of concept, to demonstrate the suitability of 
the ac-CW-based medium to produce recombinant 
proteins in L. lactis, we tested its efficiency on a previ-
ously characterized system, namely L. lactis NZ9000 
clpP− htrA− carrying the pNZ8148-MMP-9 vector cod-
ing for the catalytic domain (Phe107-Pro449, ~ 40 KDa) 
of metalloproteinase 9 (MMP-9) [44, 45]. Figure 4 shows 
the comparison between the growth curves in G-M17 
and in ac-CW with 0.05% yeast extract. The comparison 
of the growth parameters for the two conditions is pro-
vided in Table 3. Compared to the reference condition in 
rich medium, we observe again the substantial reduction 
of the final biomass accumulation. Nonetheless, when 
MMP-9 expression was induced, with 10  ng/mL nisin 
Fig. 2 Growth curves of L. lactis NZ9000 in different media. The figure shows a comparison of the growth curve of L. lactis NZ9000 in the reference 
rich medium G‑M17 (red curve) and on ac‑CW supplemented with 0.05% yeast extract as a source of cofactors and vitamins (green curve). The final 
biomass in the two conditions differs by one order of magnitude
Table 2 Comparison of the growth parameters for L. lactis 
NZ9000 in G-M17 medium and ac-CW + 0.05% yeast extract
Growth rate
µmax  (h−1)
Doubling time
td (h)
G‑M17 1.1 ± 0.2 0.6 ± 0.1
Ac‑CW + 0.05% yeast 
extract
0.6 ± 0.1 1.2 ± 0.1
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after 2  h, comparable production of recombinant pro-
tein was obtained, as visible in Fig.  5, which shows the 
western blots of the total protein lysates obtained at dif-
ferent times post-induction in the two conditions exam-
ined. Maximal accumulation of the recombinant target 
seems only slightly delayed compared to the reference 
condition.
Discussion
The possibility of reintroducing waste materials in the 
productive cycle is a central issue of bioconversions 
and of the development of circular production strate-
gies. The problem of handling the by-products of dairy 
industry has been long known: cheese whey (CW), the 
main by-product of cheese manufacturing, is a highly 
polluting waste, due to its high biological and chemical 
oxygen demand, which originates mostly from the resid-
ual lactose, but also from appreciable proteins and lipids 
content (Table  1) [29, 31]. Several strategies have been 
proposed to exploit these nutrients, reconverting them 
in added value compounds, often making use of LAB 
and of their ability of constitutively thrive on lactose. The 
growth of LAB on CW-based or CW-containing media, 
has allowed for the obtainment of various industrially rel-
evant compounds, such as bacteriocins, ethanol, organic 
acids, often with the aid of metabolic engineering [18, 20, 
21, 28, 30]. The utilization of CW as a suitable growth 
substrate, though, often requires preliminary treatments, 
which can range from complete deproteinization [20], to 
the supplementation of nutrients, with the addition of 
substantial amounts of peptone and yeast extract [21], to 
treatment with proteases or proteolytic microorganisms 
[32], and can greatly affect the sustainability and viability 
of the process. In this paper, we have described for the 
first time the possibility of using a CW-based medium 
also for the production of recombinant proteins in L. 
lactis. In the attempt of defining an industrially viable 
process, we have tried to keep the number of prelimi-
nary steps on CW prior to the cultures to a minimum, 
since pH adjustment and supplementation of catalytic 
amounts, i.e. 0.05%, of yeast extract have proven enough 
to produce acceptable biomass accumulation of L. lac-
tis NZ9000. Using such a medium, it has been possible 
to also sustain recombinant protein production with the 
nisin-inducible NICE system. We have used the pNZ4184 
vector carrying the gene coding for the sweet protein 
MNEI. This protein has been selected for its potential 
industrial application as a sugar replacer, which has moti-
vated several efforts in the past to develop strategies for 
recombinant production [35]. Its production in L. lactis, 
a GRAS host, could facilitate the use of the protein as a 
food additive. Our results clearly indicate that the choice 
of the appropriate codon usage is a fundamental requi-
site for the correct expression of the protein, contradict-
ing previous reports on the production of brazzein [46], 
for which E. coli optimized gene corresponded to higher 
production yields. In the case of MNEI, when the E. coli 
optimized gene was used, protein production was com-
pletely abated in the CW-based medium. This result 
could be related to the specific algorithm used for the E. 
coli codon usage optimization. The coding sequence was 
optimized to always use the same triplet for each codon, 
i.e. the most frequently occurring in the E. coli coding 
sequences. In almost 18% of the MNEI coding sequence, 
the E. coli preference is just the opposite of the L. lactis 
one, thus resulting in a coding sequence in which 18% of 
the codons are classified as “rare” for Lactococcus. Inter-
estingly, L. lactis is one of the few microbial species for 
Fig. 3 Production of recombinant MNEI in the ac‑CW based 
medium. Coomassie‑stained SDS‑PAGE (a) and western blot (b) of 
the total protein extract (10 μg) from L. lactis NZ9000 carrying the 
pNZ8148‑MNEI‑ll and growing on ac‑CW + 0.05% yeast extract. A: no 
induction; B: 2 h post‑induction; C: 4 h post induction; D: 16 h post 
induction; E: MNEI standard, 200 ng; F: MNEI standard, 500 ng
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which a complete tRNAome determination was carried 
out, although in a  growth condition investigated quite 
different from the two tested in the present work.
The general applicability of the CW-based medium 
has been demonstrated by producing the recombi-
nant catalytic domain of MMP-9, using the previously 
described system L. lactis NZ9000 clpP− htrA− carry-
ing the pNZ8148 vector coding for the catalytic domain 
of MMP-9 [44, 45]. Also in this case, recombinant pro-
tein production was comparable to the expression in 
standard rich medium. All the experiments described in 
this paper have been conducted in a laboratory set up, 
applying minimal control on the growth parameters, 
therefore with sub-optimal efficiency. The cultures on 
ac-CW-based medium always produced lower biomass 
than the corresponding control cultures in the standard 
medium. Even so, the yield of recombinant MNEI per 
liter of culture medium was comparable in the two condi-
tions, due to the observation of higher titers of the target 
protein in the total protein extract. We can forecast that 
the introduction of controlled oxygenation and pH alone 
will compensate for the decrease in biomass accumula-
tion. The production of organic acids throughout the 
fermentation, coupled to the lack of buffering capability 
of CW, causes in fact a quick drop in the culture pH to 
lethal values, which halts biomass accumulation. Moreo-
ver, ac-CW medium, as proposed in this paper, contains 
an unbalanced carbohydrates to proteins ratio that could 
be reduced by slight modification of the medium formu-
lation. Optimization of these parameters and the use of 
fermenters will allow greater recoveries both in biomass 
and recombinant proteins.
Conclusions
We have presented a new strategy for the production of 
two recombinant proteins in two strains of L. lactis on 
a growth medium based solely on dairy by-products. 
Through minimal manipulation and the addition of mini-
mal quantities of yeast extract, it has been possible to 
sustain microbial growth and to induce protein produc-
tion levels comparable, if not superior, to the production 
in rich medium. The simplicity of the process makes it 
suitable for the application on the industrial scale and 
Fig. 4 Comparison of the growth of L. lactis NZ9000 clpP− htrA− in different media. The figure shows a comparison of the growth curve of L. lactis 
NZ9000 clpP− htrA− carrying the pNZ8148‑MMP‑9 vector in the reference rich medium (pink curve), with the growth on ac‑CW supplemented with 
0.05% yeast extract (blue curve)
Table 3 Comparison of the growth parameters for L. lactis 
NZ9000 clpP− htrA− (pNZ8148-MMP-9) in G-M17 medium 
and ac-CW + 0.05% yeast extract
Growth rate
µmax  (h−1)
Doubling time
td (h)
G‑M17 0.8 ± 0.1 0.8 ± 0.1
Ac‑CW + 0.05% yeast 
extract
0.6 ± 0.2 1.2 ± 0.2
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prone to wide margins of improvement through the con-
trol of the growth parameters.
Methods
Bacterial strains and plasmids
Lactococcus lactis NZ9000 (pepN::nisRnisK) (NIZO) 
and the double mutant L. lactis subsp. cremoris NZ9000 
clpP− htrA− [44, 45, 49] used in this study were main-
tained as frozen glycerol stocks at − 80  °C. The  CmR 
pNZ8148 plasmid (NIZO), under nisA promoter control, 
was used in this work. MNEI was expressed in L. lactis 
NZ9000, while the catalytic domain of metalloprotein-
ase 9 (MMP-9), from Bos taurus, was produced, with a 
6×His-tag, in L. lactis NZ9000 clpP− htrA− (clpP-htrA; 
erythromycin resistant  (EmR)) (kindly provided by INRA, 
Jouy-en-Josas, France; patent nº EP1141337B1) [45, 49]. 
The gene sequences for MNEI with optimized codon 
usage for L. lactis (MNEI-ll) and E. coli (MNEI-ec) were 
purchased from Eurofins Genomics and received within 
commercial vectors. Both synthetic genes contained 
the NotI restriction enzyme site for the screening of the 
recombinant clones and were cloned into the pNZ8148 
expression vector between the NcoI and HindIII restric-
tion sites (Additional file  1: Figure S1). Plasmid isola-
tion from L. lactis cells was achieved with the PureYield 
kit (Promega) after incubation of the cells with 5 mg/mL 
Lysozyme, 2 h, 37 °C.
Compositional analysis of CW
Cheese whey (CW) from the production of ricotta was 
obtained from “Caseificio Le Terre di Don Peppe Diana” 
and stored at − 20  °C until used. Ac-CW was obtained 
by adjusting the pH of CW to 6.8, sterilization by auto-
clave and centrifugation (14,000×g, 30′, 4 °C) to remove 
the precipitate. Protein determination was performed 
by Bradford assay (Bio-rad). Carbohydrates determina-
tion was obtained by the Phenol/Sulfuric Acid assay [50]. 
Lipid determination was obtained by the Bligh & Dyer 
extraction, as reported [51].
Cell cultures
Lactococcus lactis was grown in M17 medium supple-
mented with 0.5% d-glucose (G-M17), in ac-CW and in 
ac-CW supplemented with 0.05% Yeast extract. Culture 
were kept static at 30  °C. Typically, 30 mL cultures were 
performed in 50 mL tubes. For recombinant strains, the 
growth medium was supplemented with 5  µg/mL chlo-
ramphenicol. In general, overnight cultures of L. lactis 
in G-M17 were diluted into 30 mL of culture medium to 
an OD600 of 0.1 Bacterial growth rates in G-M17 and in 
ricotta cheese whey were measured by plating appropriate 
dilutions of the culture suspension on G-M17 agar plates 
and counting the CFU after incubation at 30 °C for 24 h.
Production of MNEI and MMP-9 in L. lactis
L. lactis NZ9000 competent cells were transformed by 
electroporation with either the pNZ8148-MNEI-ll or 
pNZ8148-MNEI-ec vector [52]. Electroporation was 
performed with a Gene Pulser from Bio-rad fitted with 
2500 V, 200 X and 25 µF in a pre-cooled 2 cm electropo-
ration cuvette. Samples were then incubated for 2  h at 
30 °C in 900 µL restorative medium (G-M17 with 20 mM 
 Mg2Cl2 and 2 mM  Ca2Cl2). The electroporation mix was 
centrifuged for 10 min at 10,000×g at 4 °C and the pellet 
Fig. 5 Production of recombinant MMP9 in the G‑M17 and ac‑CW based medium. The figure shows a comparison of the western blots of 10 μg 
of total protein extract of cells of L. lactis NZ9000 clpP− htrA− transformed with the pNZ8148‑MMP9 vector after culture in rich medium (a) or in 
ac‑CW supplemented with 0.05% Yeast extract (b). A: no induction; B: 2 h post‑induction; C: 4 h post induction; D: 16 h post induction. While protein 
expression levels seem comparable in the two cases, maximum production appears slightly delayed in the case of the CW derived medium
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was resuspended in 100 µL of G-M17 media and plated. 
Recombinant cells were grown as described in the previ-
ous section. Expression of the MNEI gene was induced 
by administration of 10 ng/mL nisin in the mid-exponen-
tial phase, i.e. 2  h into the growth. At 2, 4 or 16  h post 
induction, 10  mL from the culture were harvested and 
the cells were pelleted by centrifugation (10,000×g, 4 °C, 
30′), washed twice with cold PBS, resuspended in 1 mL 
of 50  mM sodium acetate buffer, pH 5.5, and disrupted 
by sonication. The MMP-9 recombinant production was 
carried out in L. lactis NZ9000 clpP− htrA− recombinant 
with pNZ8148-MMP-9 [44], following the same condi-
tions previously described for MNEI production.
SDS-PAGE and Western blot
Total protein content of the sonicated fractions was esti-
mated by Bradford assay using BSA as standard. The 
purified recombinant MNEI from E. coli (MW ~ 11 kDa), 
obtained as described in [53], was used as positive con-
trol. Samples of 10  μg total protein extract were loaded 
on 12% SDS-PAGE and then blotted onto Immobilon-P 
transfer membrane (EMD, Millipore Corporation, USA). 
Membranes were incubated with an rabbit anti-Y65R-
MNEI antibody [36] (1:200, Primmbiotech, courtesy of 
Dr. Nunzia Scotti) and subsequently with a HRP-conju-
gated anti-rabbit antibody (1:50,000, BioFX Laborato-
ries). Detection of the His-tagged MMP-9 expression in 
L. lactis clpP− htrA− was also performed by western blot. 
The membranes were incubated with anti-poly-His Per-
oxidase conjugate (1:2000). In both cases the signal was 
revealed by enhanced chemiluminescence (ECL) kit (Bio-
rad, Clarity™ western ECL Substrate) and recorded on a 
ChemiDoc™ MP Imaging System (Biorad).
Additional files
Additional file 1: Figure S1. Alignment of the MNEI-ec and MNEI-ll gene 
sequences. Restriction sites used for cloning are indicated in blue (NcoI 
and Hind III). A NotI site (red) was included for plasmid screening.
Additional file 2: Figure S2. Effect of the codon usage on recombinant 
protein production. Western blot (B) of the total protein extract (10 μg) 
from L.lactis NZ9000 carrying the pNZ8148‑MNEI-ec vector. A: no induc‑
tion; B: 2 h post‑induction; C: 4 h post induction; D: 16 h post induction; E: 
MNEI, 50 ng; F: MNEI, 200 ng; G: MNEI, 500 ng.
Additional file 3: Figure S3. Evolution of the pH during cell culture. Plot 
of the pH vs time during the growth of L. lactis NZ9000 in G‑M17 medium 
(blue curve) and in ac‑CW + 0.05% yeast extract (red curve).
Additional file 4: Table S1. Composition of the G‑M17 medium.
Additional file 5: Figure S4. Effect of the codon usage on recombinant 
protein production in CW‑based medium. Western blot (B) of the total 
protein extract (10 μg) from L.lactis NZ9000 carrying the pNZ8148‑MNEI-
ec vector growth on ac‑CW + 0.05% yeast extract. A: no induction; B: 2 h 
post‑induction; C: 4 h post induction; D: 16 h post induction; E: MNEI, 50 
ng; F: MNEI, 200 ng; G: MNEI, 500 ng.
Abbreviations
CW: cheese whey; ac‑CW: autoclaved/centrifuged cheese whey; NICE: nisin 
controlled gene expression system.
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